Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 2023-2028

  Ishac, Edward J N ^a   Jiang, Liu ^a   Lake, Kristy D ^a   Varga, Karoly ^a   Abood, Mary E ^a   Kunos, George ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anandamide; Cannabinoids; CB1 receptors; Noradrenaline release; Presy naptic receptors; SR141716A; 9 tetrahydrocannabinol

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL; MESSENGER RNA; NORADRENALIN; RIMONABANT; TETRODOTOXIN; TYRAMINE;

ANIMAL TISSUE; ARTICLE; BRAIN; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART ATRIUM; HYPOTENSION; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; MOUSE; MUSCLE TWITCH; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC INHIBITION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE; VAS DEFERENS;

EID: 0029786614     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15639.x     Document Type: Article

References (22)

1. CHOMCZYNSKI, P. & SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
2. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, G., MANDELBAUM, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
3. 1B-adrenergic receptor gene in liver is controlled by three promoters. J. Biol. Chem., 269, 15762-15767.
4. GERARD, C.M., MOLLEREAU, C., VASSART, G. & PARMENTIER, M. (1991). Molelcular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J., 279, 129-134.
5. 3H]-(-)-noradrenaline from the isolated vas deferens of the rat. Br. J. Pharmacol., 52, 233-236.
6. HERKENHAM, M., LYNN, A.B., LITTLE, M.D., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, C.K. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A., 87, 1932-1936.
7. HOWLETT, A.C., EVANS, D.M. & HOUSTON, D.B. (1992). The cannabinoid receptor. In Marijuana/Cannabinoids/ Neurobiology & Neurophysiology. ed. Murphy, L. & Bartke, A. pp. 35-72. Boca Raton: CRC Press.
8. KAMINSKI, N.E., ABOOD, M.E., KESSLER, F.K., MARTIN, B.R. & SCHATZ, A.R. (1992). Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol., 42, 736-742.
9. KAO, C.Y. (1966). Tetrodotoxin, saxitoxin and their significance in the study of excitation phenomena. Pharmacol. Rev., 18, 997-1049.
10. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, B.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
11. MCLAUGHLIN, C.R. & ABOOD, M.E. (1993). Developmental expression of cannabinoid receptor mRNA. Dev. Brain Res., 76, 75-78.
12. MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N.E. SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R., COMPTON, D.R., PERTWEE, R.G., GRIFFIN, G., BAYEWITCH, M., BARG, J. & VOGEL, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
13. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
14. PERTWEE, R.G., STEVENSON, L.A., ELRICK. D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980-984.
15. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C, MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
16. SHIRE, D., CARILLON, C, KAGHAD, M., CALANDRA, B., RINALDICARMONA, M., LE FUR, G., CAPUT, D. & FERRARA, P. (1995). An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem., 270, 3726-3731.
17. SJOSTRAND, N.O. & SWEDIN, G. (1968). Time course of the effect of reserpine on the noradrenaline content of the vas deferens and the seminal vesicle compared with the submaxillary gland and the heart of the rat. Acta Physiol. Scand., 72, 370-377.
18. SMITH, A.D. & WINKLER, H. (1972). Fundamental mechanisms in the release of catecholamines. In Handbook of Experimental Pharmacology, ed. Blaschko, H. & Muscholl, E. vol. 33, pp. 538-617. Berlin, Heidelberg, New York: Springer.
19. SUGIURA, T., KONDO, S., SUKAGAWA, A., NAKANE. S., SHINODA, A., ITOH, K., YAMASHITA, A. & WAKU, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 89-97.
20. VARGA, K., HUANGFU, D., GUYENET, P., LAKE, K. & KUNOS, G. (1996). Mechanism of the sympathoinhibitory effect of anandamide. FASEB J., 10, A711.
21. VARGA, K., LAKE, K., MARTIN, B.R. & KUNOS, G. (1995). Novel antagonist implicates the CBl cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279-283.
22. 9-trans-tetrahydrocannabinol. J. Pharm. Pharmacol., 26, 186-192.